Our clinical investigation has also determined that increased expression of hGH mRNA correlates with poor clinical outcome in HCC patients, indicative of the functional effects of autocrine or tumor derived hGH in HCC [20]. The gene discussed is GH1; the disease is hepatocellular carcinoma.